|
|
|
Volumn 144, Issue 13, 2003, Pages 597-603
|
|
Breakthrough in breast cancer chemoprevention;Attörés az emlórák gyógyszeres prevenciója terén.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AROMATASE INHIBITOR;
ENZYME INHIBITOR;
FENRETINIDE;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
SOMATOMEDIN C;
TAMOXIFEN;
BREAST TUMOR;
FEMALE;
GENETICS;
HUMAN;
MENOPAUSE;
METABOLISM;
REVIEW;
RISK FACTOR;
TIME;
TUMOR SUPPRESSOR GENE;
ANTICARCINOGENIC AGENTS;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
ENZYME INHIBITORS;
ESTROGEN RECEPTOR MODULATORS;
FEMALE;
FENRETINIDE;
GENES, BRCA1;
GENES, BRCA2;
HUMANS;
INSULIN-LIKE GROWTH FACTOR I;
MENOPAUSE;
RALOXIFENE;
RISK FACTORS;
TAMOXIFEN;
TIME FACTORS;
|
|
EID: 0038727312
PISSN: 00306002
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (49)
|
